Please login to the form below

Therapeutic vaccines

This page shows the latest Therapeutic vaccines news and features for those working in and with pharma, biotech and healthcare.

FDA approves GSK’s Priorix vaccine for measles, mumps and rubella

Temi Folaranmi, vice president and vaccines therapeutic area head of US Medical Affairs at GSK said: “Outbreaks of measles in recent years demonstrate how quickly diseases can return without widespread immunisation. ... Outlined in a US Centers for

Latest news

Pfizer expands access to lipid nanoparticle technology in new agreement with Acuitas Therapeutics

This agreement expands our LNP capabilities and allows us to explore more projects within our existing vaccines area and new therapeutic areas where mRNA-LNP technology holds potential for success.”. ... is excited to be working with Pfizer to advance
Janssen’s RSV vaccine provides high protection against respiratory infections

Penny Heaton, Global Therapeutic Area Head, Vaccines, Janssen Research &Development.
WHO to test three more potential COVID-19 treatments

Several such trials are ongoing, including the RECOVERY trial in the UK and the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) in the US.
EU secures 405 million doses of CureVac’s COVID-19 vaccine

CureVac’s candidate, like other investigational vaccines from Pfizer and BioNTech and Moderna, uses mRNA technology, which is a relatively new research area. ... The hope is that by using mRNA technology to develop vaccines and therapeutic treatments,
CureVac reveals early data for mRNA-based COVID-19 vaccine candidate

mRNA technology has been in the spotlight during the race to develop a COVID-19 vaccine, with a number of companies utilising this research area to develop innovative vaccines for the ... The hope is that by using mRNA technology to develop vaccines and

More from news
Approximately 0 fully matching, plus 31 partially matching documents found.

Latest Intelligence

Switzerland: a life sciences hub

A partial revision to the Swiss Patents Act and its implementing provisions came into force on 1 January 2019, together with an ordinary revision of the Therapeutic Products Act. ... For example, over the last five years, Lundbeck acquired Prexton
Biotech profile: Tom Evans, CEO, Vaccitech.

You have a broad pipeline of candidates, including therapeutic vaccines, such as your vaccine for prostate cancer in phase 1. ... How big a role do you think therapeutic vaccines will play in future cancer treatment?
Cancer immunotherapy: What's on the horizon?

Researchers are now trying to identify biomarker-based subgroups and drug combinations to try to improve therapeutic outcomes for patients. ... Vaccines. While the first therapeutic cancer vaccines have reached the market, eg Dendreon’s Provenge and
Deal Watch table for January 2015

Exclusive licence. 522. AC Immune/ Janssen. To develop and commercialise therapeutic anti-Tau vaccines [ACI35, P1] for the treatment of Alzheimer's disease. ... 3 year research collaboration and exclusive licence. 509. Neuropore Therapies/UCB. To develop
Pharma deals during July 2014

Baxter forecasts that its revenues from vaccines will be approximately $300m for 2014. ... CureVac is also eligible to receive clinical, regulatory and commercial milestones of up to $202m, as well as royalty payments associated with products sales of

More from intelligence
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest appointments

Neon Therapeutics taps Dr Richard Gaynor for R&D leadership role

At Cambridge, US-based Neon he will be tasked with guiding the immuno-oncology company's research programmes, which are focused on developing neoantigen-based therapeutic vaccines and T cell therapies.
Bionor names executive management team additions

Together, they bring a wealth of experience to advance therapeutic vaccines for Bionor, and specifically will add operational strength to get our HIV functional cure approach advanced to patients and the

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs

Lead Market Access Writer, £5K joining bonus, UK: Highly competitive salary

Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...: Highly competitive salary

Market Access Director, six figure base salary and £5K joining b...: Highly competitive salary

Principal Medical Writer, Facial Aesthetics, Medical Communicati...: 65-75K

Exciting Medical Writer Career Opportunity for Postdoc, Medcomms: Highly competitive salary

PMHub

Add my company

Origins - The Patient Focused Specialists

Origins creates and delivers patient focused strategy, insights, data and solutions, which guides pharma and biotech companies to improve value...

Latest intelligence

Virtual Steering Committee & Peer Influence Program: In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
Meeting healthcare’s rising challenges: The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
Report gives insights to address gaps in HCP engagement: How does Pharma-HCP engagement need to evolve in today's digital landscape?...

Email:
Password:

Please login to the form below

Therapeutic vaccines

Subscribe to our email news alerts

Featured jobs

Quick links